Global alignment of immunization safety assessment in pregnancy - The GAIA project.

[1]  E. Sell,et al.  Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation , 2017, Vaccine.

[2]  S. Kochhar,et al.  Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy☆ , 2016, Vaccine.

[3]  S. Kochhar,et al.  Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women. , 2016, Vaccine.

[4]  S. Kochhar,et al.  Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data , 2016, Vaccine.

[5]  S. Kochhar,et al.  Postpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data☆ , 2016, Vaccine.

[6]  Tresor Bodjick Muena Mujobu,et al.  Non-reassuring fetal status: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data , 2016, Vaccine.

[7]  S. Kochhar,et al.  Maternal death: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data☆ , 2016, Vaccine.

[8]  S. Kochhar,et al.  Pathways to preterm birth: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data☆ , 2016, Vaccine.

[9]  S. Kochhar,et al.  Hypertensive disorders of pregnancy: Case definitions & guidelines for data collection, analysis, and presentation of immunization safety data , 2016, Vaccine.

[10]  Wendy Watson,et al.  Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data , 2016, Vaccine.

[11]  S. Kochhar,et al.  Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data☆ , 2016, Vaccine.

[12]  Jyoti Joshi,et al.  Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data , 2016, Vaccine.

[13]  S. Kochhar,et al.  Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data☆ , 2016, Vaccine.

[14]  S. Omer,et al.  A systematic review of adverse events following immunization during pregnancy and the newborn period , 2015, Vaccine.

[15]  J. Bauwens,et al.  Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions , 2015, Vaccine.

[16]  Stephanie A. Jones,et al.  Influenza vaccination of pregnant women and protection of their infants. , 2014, The New England journal of medicine.

[17]  Robert T. Chen,et al.  Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines. , 2013, Vaccine.

[18]  H. Larson,et al.  Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization. , 2013, Vaccine.

[19]  A. Shane.  Effectiveness of Maternal Influenza Immunization in Mothers and Infants , 2009 .

[20]  M. Zillikens,et al.  Images in clinical medicine. Extracapsular hemorrhage from a parathyroid adenoma. , 2008, The New England journal of medicine.

[21]  U. Heininger,et al.  Adverse events following immunization: perception and evidence , 2007, Current opinion in infectious diseases.